Pediatric Lactulose Dosing for Constipation
For pediatric constipation, initiate lactulose at 2.5-10 mL/day in divided doses for infants, and 40-90 mL/day for older children and adolescents, titrating to achieve 2-3 soft stools daily. 1
Initial Dosing by Age
The FDA-approved dosing provides clear age-based guidance 1:
- Infants: Start with 2.5-10 mL/day in divided doses
- Older children and adolescents: Start with 40-90 mL/day total daily dose
The subjective goal is to produce 2-3 soft stools daily. If the initial dose causes diarrhea, reduce immediately and discontinue if diarrhea persists 1.
Titration Strategy
After initiating therapy, adjust the dose based on clinical response rather than fixed schedules. The evidence shows that weight-adjusted dosing (approximately 1-2 mL/kg/day) can be used as a starting framework 2, 3, though the FDA label emphasizes titrating to stool output rather than strict weight-based calculations 1.
Research demonstrates that initial lactulose doses averaging 1.99±0.43 mL/kg/day for children under 8 years and 1.26±0.25 mL/kg/day for children 8-12 years are commonly effective 2. However, individual response varies significantly, and colon transit time does not reliably predict the required maintenance dose 2.
Critical Dosing Considerations
Avoid overdosing: There is a dangerous misconception that larger doses remedy lack of effect from smaller amounts. Overuse leads to serious complications including aspiration, dehydration, hypernatremia, severe perianal irritation, and can paradoxically precipitate encephalopathy in vulnerable patients 4.
Monitor for adverse effects: The most common side effects are dose-dependent bloating and flatulence 5. In infants specifically, watch for hyponatremia and dehydration 1.
Maintenance Therapy
Once adequate stool frequency is achieved, continue the effective dose long-term. Evidence shows that weight-adjusted dosing remains stable over years of follow-up, with increases in total daily dose primarily reflecting patient growth rather than tolerance development 6. The median weight-adjusted dose remains around 1.88-1.89 mg/kg over extended follow-up periods 6.
Comparative Effectiveness
While lactulose is widely used and FDA-approved for pediatric constipation, research suggests liquid paraffin may produce faster response with fewer side effects 3, and polyethylene glycol (PEG) may reduce colonic transit time more effectively 7. However, lactulose remains a reasonable first-line option given its established safety profile and lower cost 4, 5.
For patients experiencing significant bloating or inadequate response, consider switching to PEG rather than escalating lactulose doses indefinitely 5, 7.
Weaning Strategy
When discontinuing after successful long-term treatment (>3 months), gradual reduction over 3 months is recommended, though success rates remain modest (approximately 60-70% at 12 weeks) 6. Pre-weaning doses exceeding 1.5 g/kg/day may predict better weaning outcomes 6.